March 29, 2025 The Best Source of News, Culture, Lifestyle for Culver City, Mar Vista, Del Rey, Palms and West Los Angeles

Cedars-Sinai Develops New Gene Therapy to Combat Lou Gehrig’s Disease

Cedars-Sinai announced Thursday its regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of Lou Gehrig’s disease.

The approval allows patients to receive a new investigational drug in a few months when the study begins at the Cedar-Sinai Board of Governors Regenerative Medicine Institute.

This will be the first clinical trial to test the safety of this type of therapy, developed with the intention of preserving leg mobility in patients with Lou Gehrig’s disease, also called amyotrophic lateral sclerosis, which attacks motor neurons, cells that control muscles.

Enrollment could begin by the end of this year.

There is no effective treatment for the disease, only medications to alleviate symptoms, such as muscle spasms, or mechanical devices to help patients breathe. As a result, this clinical trial is seen by many as significant.

“Any time you’re trying to treat an incurable disease, it is a long shot, but we believe the rationale behind our new approach is strong,” said Clive Svendsen, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, who has spent a dozen years developing the new approach.

The new approach, funded by the California Institute for Regenerative Medicine and outlined in a 4,600-page application to the FDA, involves engineering stem cells to produce an important protein — glial cell line derived neurotrophic factor. The stem cells producing GDNF then can protect the motor neurons that allow impulses to pass from the brain or spinal cord to a muscle.

When a healthy person wants to move a leg, for example, the brain sends a signal along that pathway to the motor neuron that enables the movement. Patients with ALS develop progressive paralysis as the disease causes motor neurons to die.

Motor neurons that die in ALS don’t exist in a vacuum — they have support cells called glia that enable the motor neurons to live and operate,” said Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine.

“What we and others have found in ALS is that the support cells become sick and lack certain proteins that keep motor neurons alive. When the support cells die, the motor neurons also die, causing paralysis that gets worse and worse until the patient can no longer move.”

Svendsen and his team reasoned that if they could keep motor neurons alive by providing the supporting glial cells that make the necessary protein, then perhaps they could improve leg mobility.

Their theory spurred the team to develop this combined stem cell and gene therapy approach. The stem cells engineered to produce GDNF are replicated until billions of cells are formed.

When the protein-enhanced stem cells are infused into the patient’s spinal cord, they generate glial support cells that produce GDNF. The hope is that these support cells will, in turn, keep the motor neurons alive.

“This is a highly innovative approach to a disease that has mystified medicine for generations,” said Dr. Shlomo Melmed, Cedars-Sinai executive vice president for Academic Affairs, dean of the medical faculty and the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine.

The combination of cutting-edge stem cell science, developing a new device to inject the cells, our outstanding research laboratories and the direct involvement of neuroscientists, neurosurgeons and neurologists made this CIRM-funded project possible.”

The stem cell implantations for ALS patients involved in the clinical trial could begin by the end of the year, Svendsen said.

Participants will come from the ALS Clinic at Cedars-Sinai, and the trial will be led by Dr. Robert Baloh and Peggy Allred. The neurosurgical team will be led by Dr. J. Patrick Johnson.

Patients eligible to be considered for the trial must be experiencing ALS-caused weakness in their legs. Cell implantations will take place during a five-hour surgical procedure in which a neurosurgeon will remove a piece of bone in the lumbar region of the patient’s lower back.

Using an investigational device developed specifically for this trial, the surgeon will inject the stem cells directly into the patient’s spinal cord in a section that governs movement on only one side of the body.

Neither the patients nor the physicians caring for the patients will know which side has received the stem cells.

“We will follow the patients for a year and measure the strength in each leg,” Svendsen said.

“In ALS, usually the legs lose strength at the same time. This is a small safety trial to ensure the cells releasing GDNF do not have any negative effects on leg function. If safe, we plan a larger future trial to see if this therapy can improve strength in the treated leg.”

Patients seeking information about potentially participating in the clinical trial should call (310) 423-1791.

The research leading to the clinical trial has been funded by a $16.8 million grant from the California Institute for Regenerative Medicine.

 

Cedars-Sinai

Related Posts

Judge to L.A. Leaders: ‘I Am Your Worst Nightmare’ in Scathing Homeless Spending Rebuke

March 28, 2025

March 28, 2025

Carter Warns of Court Intervention if City and County Fail to Fix Broken Systems U.S. District Judge David O. Carter,...

Mayor Karen Bass Texts Sent During the Palisades Fire Have Been Released

March 28, 2025

March 28, 2025

Newly Recovered Texts Were Recovered After Sharp Criticism Over Deletions As wildfires swept through Los Angeles in early January, Mayor...

Serial Fraudster Swindled $18M From Investors in Fake Hemp Ventures

March 28, 2025

March 28, 2025

Feds Seize Ferrari, Real Estate as Judge Jails Beverly Hills ‘Con Man’ Mark Roy Anderson, 70, of Beverly Hills, was...

Music Mogul Convicted, West Hollywood Co-Defendant Heads to Trial

March 28, 2025

March 28, 2025

West Hollywood Talent Executive Awaits Trial in Multi-Count Kingpin Act ​A federal jury has convicted José Ángel Del Villar, 44,...

Culver City Police Nab Eight in Overnight Burglary, Series of Drug Arrests

March 28, 2025

March 28, 2025

Two Arrested for Burglary, Six More Booked for Narcotics  Culver City Police made a series of arrests in the last...

LAPD Sets Weekend DUI Checkpoints and Saturation Patrols Across West Los Angeles

March 28, 2025

March 28, 2025

Checkpoints Begin Friday, March 28; Patrols to Follow Throughout the Weekend Officials announced that the Los Angeles Police Department will...

Film Review: A Working Man

March 27, 2025

March 27, 2025

By Dolores Quintana A Working Man is the second collaboration between director David Ayer and actor Jason Statham, in which...

Cocktail Season Arrives in Brentwood While Beverly Hills Hosts Wine Dinner Affair

March 27, 2025

March 27, 2025

Bar Toscana Unveils Spring Cocktails as Nerano Prepares Wine-Paired Feast Bar Toscana is welcoming spring with a lineup of vibrant...

Exclusive Omakase Experience Comes to Beverly Hills for Four Weeks Only

March 27, 2025

March 27, 2025

Dine Under the Stars: Chef Wei Chen’s Omawei Takes Over The Belvedere Acclaimed chef Wei Chen is set to debut...

Culver City Gets a Taste of Italy with Bernie’s All-Natural Shaved Ice Pop-Up

March 27, 2025

March 27, 2025

Toasted Meringue Meets Farm-Fresh Granita at Citizen Market  A sweet new addition has arrived just in time for spring at...

Osteria Mamma Rings in 15 Years with New Chef and Tasting Events

March 27, 2025

March 27, 2025

From Pasta to Pinot: Osteria Mamma Kicks Off Anniversary with Flavor Osteria Mamma, a longtime favorite in Larchmont Village, is...

Green Beans and Beef Sticks Recalled in California Over Contamination Risks

March 27, 2025

March 27, 2025

Officials Warn Consumers to Discard or Return Affected Products The U.S. Food and Drug Administration announced that Del Monte Foods...

Duke’s Malibu Sends Message of Aloha After Mudslide Closure

March 26, 2025

March 26, 2025

We’ll Be Back: Reopening After Natural Disaster Planned Duke’s Malibu, a popular beachfront restaurant on the Pacific Coast Highway, has...

End of an Era: Garcelle Beauvais Announces Departure From RHOBH

March 26, 2025

March 26, 2025

Goodbye, Beverly Hills! Garcelle Beauvais Confirms RHOBH Departure Actress, producer, and star of the famed Beverly Hills-based reality show Garcelle...

‘Cell Phone Theft Capital’? West Hollywood Struggles with Pickpocketing Spike

March 26, 2025

March 26, 2025

Pickpocketing Surges in West Hollywood’s Rainbow District The West Hollywood Sheriff’s Department has reported a sharp increase in pickpocket thefts...